Literature DB >> 33782651

Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2.

Manjesh Saakre1, Deepu Mathew2, V Ravisankar2.   

Abstract

BACKGROUND: The world pandemic COVID-19 caused by SARS-CoV-2 is currently claiming thousands of lives. Flavonoids abundantly present in the fruits and vegetables, especially quercetin, are shown to have antiviral activities. MAIN TEXT: This paper reviews the capability of the plant flavonoid quercetin to fight the novel coronavirus and the possibility for drug development based on this. The mode of action explaining the known pathways through which this molecule succeeds in the antiviral activity, action of quercetin on SARS-CoV-2 main protease 3CLpro, antiviral activities of its derivatives on human viruses, effect of combination of zinc co-factor along with quercetin in the COVID-19 treatment, and the regulation of miRNA genes involved in the viral pathogenesis are discussed. Proof for this concept is provided following the virtual screening using ten key enzymes of SARS-CoV-2 and assessing their interactions. Active residues in the 3D structures have been predicted using CASTp and were docked against quercetin. Key proteins 3CLpro, spike glycoprotein/ human ACE2-BOAT1 complex, RNA-dependent RNA polymerase, main peptidase, spike glycoprotein, RNA replicase, RNA binding protein, papain-like protease, SARS papain-like protease/ deubiquitinase, and complex of main peptidase with an additional Ala at the N-terminus of each protomer, have shown the binding energies ranging between - 6.71 and - 3.37 kcal/ Mol, showing that quercetin is a potential drug candidate inhibiting multiple SARS-CoV-2 enzymes.
CONCLUSION: The antiviral properties of flavonoid and the molecular mechanisms involved are reviewed. Further, proof for this concept is given by docking of key proteins from SARS-CoV-2 with quercetin.
© The Author(s) 2021.

Entities:  

Keywords:  3CLpro; Antiviral; COVID-19; Drug design; Phytomedicine; Zinc; miRNA

Year:  2021        PMID: 33782651      PMCID: PMC7989718          DOI: 10.1186/s43088-021-00107-w

Source DB:  PubMed          Journal:  Beni Suef Univ J Basic Appl Sci        ISSN: 2314-8535


  78 in total

1.  Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.

Authors:  Kiira Ratia; Kumar Singh Saikatendu; Bernard D Santarsiero; Naina Barretto; Susan C Baker; Raymond C Stevens; Andrew D Mesecar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

2.  Antiviral effect of flavonoids on human viruses.

Authors:  T N Kaul; E Middleton; P L Ogra
Journal:  J Med Virol       Date:  1985-01       Impact factor: 2.327

3.  Therapeutic options for the 2019 novel coronavirus (2019-nCoV).

Authors:  Guangdi Li; Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2020-03       Impact factor: 84.694

4.  Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection.

Authors:  Xiangguo Qiu; Andrea Kroeker; Shihua He; Robert Kozak; Jonathan Audet; Majambu Mbikay; Michel Chrétien
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

5.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.

Authors:  Zhenming Jin; Xiaoyu Du; Yechun Xu; Yongqiang Deng; Meiqin Liu; Yao Zhao; Bing Zhang; Xiaofeng Li; Leike Zhang; Chao Peng; Yinkai Duan; Jing Yu; Lin Wang; Kailin Yang; Fengjiang Liu; Rendi Jiang; Xinglou Yang; Tian You; Xiaoce Liu; Xiuna Yang; Fang Bai; Hong Liu; Xiang Liu; Luke W Guddat; Wenqing Xu; Gengfu Xiao; Chengfeng Qin; Zhengli Shi; Hualiang Jiang; Zihe Rao; Haitao Yang
Journal:  Nature       Date:  2020-04-09       Impact factor: 49.962

6.  Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.

Authors:  Syed Ovais Aftab; Muhammad Zubair Ghouri; Muhammad Umer Masood; Zeshan Haider; Zulqurnain Khan; Aftab Ahmad; Nayla Munawar
Journal:  J Transl Med       Date:  2020-07-07       Impact factor: 5.531

Review 7.  Molecular Targets of Genistein and Its Related Flavonoids to Exert Anticancer Effects.

Authors:  Hee-Sung Chae; Rong Xu; Jae-Yeon Won; Young-Won Chin; Hyungshin Yim
Journal:  Int J Mol Sci       Date:  2019-05-16       Impact factor: 5.923

8.  Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly.

Authors:  Padmanaban Senthilvel; Pandian Lavanya; Kalavathi Murugan Kumar; Rayapadi Swetha; Parimelzaghan Anitha; Susmita Bag; Sundaramoorthy Sarveswari; Vijayaparthasarathi Vijayakumar; Sudha Ramaiah; Anand Anbarasu
Journal:  Bioinformation       Date:  2013-11-11

9.  Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.

Authors:  Müşerref Duygu Saçar Demirci; Aysun Adan
Journal:  PeerJ       Date:  2020-06-05       Impact factor: 2.984

Review 10.  Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells.

Authors:  Asma Vafadar; Zahra Shabaninejad; Ahmad Movahedpour; Farzaneh Fallahi; Mona Taghavipour; Younes Ghasemi; Maryam Akbari; Alimohammad Shafiee; Sarah Hajighadimi; Sanaz Moradizarmehri; Ebrahim Razi; Amir Savardashtaki; Hamed Mirzaei
Journal:  Cell Biosci       Date:  2020-03-10       Impact factor: 7.133

View more
  12 in total

Review 1.  The vital role of animal, marine, and microbial natural products against COVID-19.

Authors:  Aljawharah A Alqathama; Rizwan Ahmad; Ruba B Alsaedi; Raghad A Alghamdi; Ekram H Abkar; Rola H Alrehaly; Ashraf N Abdalla
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 2.  The SARS-CoV-2 main protease (Mpro): Structure, function, and emerging therapies for COVID-19.

Authors:  Qing Hu; Yuan Xiong; Guang-Hao Zhu; Ya-Ni Zhang; Yi-Wen Zhang; Ping Huang; Guang-Bo Ge
Journal:  MedComm (2020)       Date:  2022-07-14

3.  Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: A probable prelude to control some variants of coronavirus including Delta.

Authors:  Suliman Khan; Arif Hussain; Yasaman Vahdani; Hamideh Kooshki; Bashdar Mahmud Hussen; Setareh Haghighat; Mohammed Fatih Rasul; Hazha Jamal Hidayat; Anwarul Hasan; Zehra Edis; Samir Haj Bloukh; Shahab Kasravi; Mohammad Mahdi Nejadi Babadaei; Majid Sharifi; Qian Bai; Jianbo Liu; Bowen Hu; Keivan Akhtari; Mojtaba Falahati
Journal:  Arab J Chem       Date:  2021-07-28       Impact factor: 5.165

Review 4.  Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.

Authors:  Hong Zhou; Wei-Jian Ni; Wei Huang; Zhen Wang; Ming Cai; Yan-Cai Sun
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

Review 5.  Targeting autophagy with natural products to prevent SARS-CoV-2 infection.

Authors:  Chiara Vidoni; Andréa Fuzimoto; Alessandra Ferraresi; Ciro Isidoro
Journal:  J Tradit Complement Med       Date:  2021-10-14

Review 6.  Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation.

Authors:  Santoshi Sahu; C R Patil; Sachin Kumar; Subbu Apparsundaram; Ramesh K Goyal
Journal:  Mol Cell Biochem       Date:  2021-10-16       Impact factor: 3.842

Review 7.  Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.

Authors:  Priyanka Saha; Subhankar Bose; Amit Kumar Srivastava; Anis Ahmad Chaudhary; Rajiv Lall; Sahdeo Prasad
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

8.  An In-silico Screening Strategy to the Prediction of New Inhibitors of COVID-19 Mpro Protein.

Authors:  Maryam Abbasi; Hojjat Sadeghi-Aliabadi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

9.  Associations of Nutritional Behavior and Gut Microbiota with the Risk of COVID-19 in Healthy Young Adults in Poland.

Authors:  Paweł Jagielski; Edyta Łuszczki; Dominika Wnęk; Agnieszka Micek; Izabela Bolesławska; Beata Piórecka; Paweł Kawalec
Journal:  Nutrients       Date:  2022-01-14       Impact factor: 5.717

Review 10.  Molecular Targets of Natural Compounds with Anti-Cancer Properties.

Authors:  Małgorzata Kubczak; Aleksandra Szustka; Małgorzata Rogalińska
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.